iBiopsy®: Promising Results on a Preliminary Study to Identify the Severity of the Disease in Patients With Non-Alcoholic Steatohepatitis (NASH)
Median Technologies study on severity of hepatic fibrosis in Non-Alcoholic Steatohepatitis (NASH). (Credit: Michal Jarmoluk from Pixabay.)